1-8 of 8
Maria Wysocka
Close
Sort by
Journal Articles

CRISPR-Cas9 Knock out of CD5 Enhances the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells

Inkook Chun, MS, Ki Hyun Kim, PhD, Yi-Hao Chiang, MD, Wei Xie, MD, Yong Gu Gu Lee, PhD, Raymone Pajarillo, MS, Antonia Rotolo, MD PhD, Olga Shestova, PhD, Seok Jae Hong, MS, Mohamed Abdel-Mohsen, PhD, Maria Wysocka, PhD, Hatcher J. Ballard, BS, David M. Barrett, Avery D. Posey, PhD, Daniel Powell, Jr., PhD, Saar I. Gill, MDPhD, Stephen J. Schuster, MD, Stefan K. Barta, MDMRCP,MS, Alain H Rook, MD, Carl H June, MD, Marco Ruella, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–52.
https://doi.org/10.1182/blood-2020-136860
Published: 2020
Journal Articles

Epiproteomic Landscape and Histone Code of Cutaneous T-Cell Lymphoma/Sézary Syndrome

Ozlem Onder, PhD MSc, Rui Wu, MDPhD, Maria Wysocka, PhD, Paul L. Haun, MD, Ellen Kim, MD, Benjamin A Garcia, PhD, David Bahler, MD, Alain Rook, MD, Megan S. Lim, MD,PhD, Kojo S.J. Elenitoba-Johnson, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 780.
https://doi.org/10.1182/blood-2018-99-115347
Published: 2018
Journal Articles

Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma

Clinical Trials & Observations
Alain H. Rook, Joel M. Gelfand, Maria Wysocka, Andrea B. Troxel, Bernice Benoit, Christian Surber, Rosalie Elenitsas, Marie A. Buchanan, Deborah S. Leahy, Rei Watanabe, Ilan R. Kirsch, Ellen J. Kim, Rachael A. Clark
Journal: Blood
Blood (2015) 126 (12): 1452–1461.
https://doi.org/10.1182/blood-2015-02-630335
Published: 2015
Includes: Supplemental data
Journal Articles

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-α receptor

Julie H. Lin, Ellen J. Kim, Anand Bansal, John Seykora, Stephen K. Richardson, Xian-Yuan Cha, Sarosh Zafar, Sunita Nasta, Maria Wysocka, Bernice Benoit, Alain H. Rook, Steven S. Fakharzadeh
Journal: Blood
Blood (2008) 112 (6): 2484–2488.
https://doi.org/10.1182/blood-2008-03-141424
Published: 2008
Journal Articles

Impaired CD40L signaling is a cause of defective IL-12 and TNF-α production in Sézary syndrome: circumvention by hexameric soluble CD40L

Lars E. French, Bertrand Huard, Maria Wysocka, Ryan Shane, Emmanuel Contassot, Jean-François Arrighi, Vincent Piguet, Silvio Calderara, Alain H. Rook
Journal: Blood
Blood (2005) 105 (1): 219–225.
https://doi.org/10.1182/blood-2004-03-1055
Published: 2005
Journal Articles

Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15

Maria Wysocka, Bernice M. Benoit, Sarah Newton, Livio Azzoni, Luis J. Montaner, Alain H. Rook
Journal: Blood
Blood (2004) 104 (13): 4142–4149.
https://doi.org/10.1182/blood-2004-03-1190
Published: 2004
Journal Articles

Where have all the T cells gone?

Alain H. Rook, Maria Wysocka
Journal: Blood
Blood (2003) 102 (12): 3859–3860.
https://doi.org/10.1182/blood-2003-09-3228
Published: 2003
Journal Articles

Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines

Maria Wysocka, Mohamed H. Zaki, Lars E. French, Jihed Chehimi, Michael Shapiro, Suzanne E. Everetts, Karen S. McGinnis, Luis Montaner, Alain H. Rook
Journal: Blood
Blood (2002) 100 (9): 3287–3294.
https://doi.org/10.1182/blood-2002-01-0231
Published: 2002